UTRS

Healthcare Medical Devices

Minerva Surgical, Inc.

$0.00
-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap
887.866
Avg Volume
21
EPS
-$7.49
52W High
$0.00
52W Low
$0.00
Div. Yield
0.0%

Valuation

Forward P/E
-0.00
P/B Ratio
0.00
P/S Ratio
0.00
EV/EBITDA
-1.27
EV/Revenue
0.63

Margins

Gross Margin 54.2%
Operating Margin (50.9%)
Net Margin (64.7%)
EBITDA Margin (49.4%)

Growth & Returns

Revenue Growth (YoY)
(4.9%)
Return on Equity
(160.1%)
Return on Assets
(27.3%)

Liquidity & Leverage

Current Ratio
1.88
Quick Ratio
0.88
Debt / Equity
2.15
Total Cash
11.13M
Total Debt
43.55M

About

Minerva Surgical, Inc. provides a suite of devices to treat the root causes of abnormal uterine bleeding in the United States. The company provides Minerva Endometrial Ablation System, a technology that uses three methods of tissue ablation; Symphion System that is designed for fluid management, direct intrauterine pressure monitoring, and bladeless resection work; and Genesys HTA, an endometrial ablation device for the treatment of a wider range of uterine cavities. It also offers Resectr, a tissue resection device to diagnose and treat polyps; and HERizon electronic disposable hysteroscope, image processor, Hysto-Kit, and endoscopic accessories that helps gynecologists to evaluate abnormal uterine bleeding and provide care. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

minervasurgical.com